United States Cancer Immunotherapy Market Report 2017

January 2017 | 116 pages | ID: UBE295D0C78EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Immunotherapy

Revenue, means the sales value of Cancer Immunotherapy

This report studies sales (consumption) of Cancer Immunotherapy in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• AstraZeneca
• F. Hoffman La-Roche
• Bayer AG
• Bristol-Myers Squibb
• Eli Lilly and Company
• Janssen Global Services
• Merck
• Novartis
• Pfizer
• Seattle Genetics
• Peregrine Pharmaceuticals
• Viralytics Ltd
• Immunomedics

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Melanoma
• Colorectal cancer
• Prostate cancer
• Head and neck cancer
• Breast cancer
• Lung cancer
• Other

Split by applications, this report focuses on sales, market share and growth rate of Cancer Immunotherapy in each application, can be divided into

• Hospitals
• Clinics
• Others

Contents

United States Cancer Immunotherapy Market Report 2017

1 CANCER IMMUNOTHERAPY OVERVIEW

1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Classification of Cancer Immunotherapy
  1.2.1 Melanoma
  1.2.2 Colorectal cancer
  1.2.3 Prostate cancer
  1.2.4 Head and neck cancer
  1.2.5 Breast cancer
  1.2.6 Lung cancer
  1.2.7 Other
1.3 Application of Cancer Immunotherapy
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Cancer Immunotherapy (2011-2021)
  1.4.1 United States Cancer Immunotherapy Sales and Growth Rate (2011-2021)
  1.4.2 United States Cancer Immunotherapy Revenue and Growth Rate (2011-2021)

2 UNITED STATES CANCER IMMUNOTHERAPY COMPETITION BY MANUFACTURERS

2.1 United States Cancer Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Immunotherapy Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Immunotherapy Average Price by Manufactures (2015 and 2016)
2.4 Cancer Immunotherapy Market Competitive Situation and Trends
  2.4.1 Cancer Immunotherapy Market Concentration Rate
  2.4.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CANCER IMMUNOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Cancer Immunotherapy Sales and Market Share by States (2011-2016)
3.2 United States Cancer Immunotherapy Revenue and Market Share by States (2011-2016)
3.3 United States Cancer Immunotherapy Price by States (2011-2016)

4 UNITED STATES CANCER IMMUNOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Cancer Immunotherapy Sales and Market Share by Type (2011-2016)
4.2 United States Cancer Immunotherapy Revenue and Market Share by Type (2011-2016)
4.3 United States Cancer Immunotherapy Price by Type (2011-2016)
4.4 United States Cancer Immunotherapy Sales Growth Rate by Type (2011-2016)

5 UNITED STATES CANCER IMMUNOTHERAPY SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Cancer Immunotherapy Sales and Market Share by Application (2011-2016)
5.2 United States Cancer Immunotherapy Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES CANCER IMMUNOTHERAPY MANUFACTURERS PROFILES/ANALYSIS

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cancer Immunotherapy Product Type, Application and Specification
    6.1.2.1 Melanoma
    6.1.2.2 Colorectal cancer
  6.1.3 Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Cancer Immunotherapy Product Type, Application and Specification
    6.2.2.1 Melanoma
    6.2.2.2 Colorectal cancer
  6.2.3 AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 F. Hoffman La-Roche
  6.3.2 Cancer Immunotherapy Product Type, Application and Specification
    6.3.2.1 Melanoma
    6.3.2.2 Colorectal cancer
  6.3.3 F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Bayer AG
  6.4.2 Cancer Immunotherapy Product Type, Application and Specification
    6.4.2.1 Melanoma
    6.4.2.2 Colorectal cancer
  6.4.3 Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Cancer Immunotherapy Product Type, Application and Specification
    6.5.2.1 Melanoma
    6.5.2.2 Colorectal cancer
  6.5.3 Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly and Company
  6.6.2 Cancer Immunotherapy Product Type, Application and Specification
    6.6.2.1 Melanoma
    6.6.2.2 Colorectal cancer
  6.6.3 Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Janssen Global Services
  6.7.2 Cancer Immunotherapy Product Type, Application and Specification
    6.7.2.1 Melanoma
    6.7.2.2 Colorectal cancer
  6.7.3 Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Merck
  6.8.2 Cancer Immunotherapy Product Type, Application and Specification
    6.8.2.1 Melanoma
    6.8.2.2 Colorectal cancer
  6.8.3 Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.2 Cancer Immunotherapy Product Type, Application and Specification
    6.9.2.1 Melanoma
    6.9.2.2 Colorectal cancer
  6.9.3 Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Pfizer
  6.10.2 Cancer Immunotherapy Product Type, Application and Specification
    6.10.2.1 Melanoma
    6.10.2.2 Colorectal cancer
  6.10.3 Pfizer Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Seattle Genetics
6.12 Peregrine Pharmaceuticals
6.13 Viralytics Ltd
6.14 Immunomedics

7 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

7.1 Cancer Immunotherapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Immunotherapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Immunotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CANCER IMMUNOTHERAPY MARKET FORECAST (2016-2021)

11.1 United States Cancer Immunotherapy Sales, Revenue Forecast (2016-2021)
11.2 United States Cancer Immunotherapy Sales Forecast by Type (2016-2021)
11.3 United States Cancer Immunotherapy Sales Forecast by Application (2016-2021)
11.4 Cancer Immunotherapy Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Immunotherapy
Table Classification of Cancer Immunotherapy
Figure United States Sales Market Share of Cancer Immunotherapy by Type in 2015
Figure Melanoma Picture
Figure Colorectal cancer Picture
Figure Prostate cancer Picture
Figure Head and neck cancer Picture
Figure Breast cancer Picture
Figure Lung cancer Picture
Figure Other Picture
Table Application of Cancer Immunotherapy
Figure United States Sales Market Share of Cancer Immunotherapy by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure United States Cancer Immunotherapy Sales and Growth Rate (2011-2021)
Figure United States Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Table United States Cancer Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Sales Share by Manufacturers
Figure 2016 Cancer Immunotherapy Sales Share by Manufacturers
Table United States Cancer Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 United States Cancer Immunotherapy Revenue Share by Manufacturers
Table United States Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015
Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers
Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers
Table United States Cancer Immunotherapy Sales by States (2011-2016)
Table United States Cancer Immunotherapy Sales Share by States (2011-2016)
Figure United States Cancer Immunotherapy Sales Market Share by States in 2015
Table United States Cancer Immunotherapy Revenue and Market Share by States (2011-2016)
Table United States Cancer Immunotherapy Revenue Share by States (2011-2016)
Figure Revenue Market Share of Cancer Immunotherapy by States (2011-2016)
Table United States Cancer Immunotherapy Price by States (2011-2016)
Table United States Cancer Immunotherapy Sales by Type (2011-2016)
Table United States Cancer Immunotherapy Sales Share by Type (2011-2016)
Figure United States Cancer Immunotherapy Sales Market Share by Type in 2015
Table United States Cancer Immunotherapy Revenue and Market Share by Type (2011-2016)
Table United States Cancer Immunotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Immunotherapy by Type (2011-2016)
Table United States Cancer Immunotherapy Price by Type (2011-2016)
Figure United States Cancer Immunotherapy Sales Growth Rate by Type (2011-2016)
Table United States Cancer Immunotherapy Sales by Application (2011-2016)
Table United States Cancer Immunotherapy Sales Market Share by Application (2011-2016)
Figure United States Cancer Immunotherapy Sales Market Share by Application in 2015
Table United States Cancer Immunotherapy Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Immunotherapy Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Cancer Immunotherapy Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Cancer Immunotherapy Sales Market Share (2011-2016)
Table F. Hoffman La-Roche Basic Information List
Table F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffman La-Roche Cancer Immunotherapy Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Cancer Immunotherapy Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Immunotherapy Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company Cancer Immunotherapy Sales Market Share (2011-2016)
Table Janssen Global Services Basic Information List
Table Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Global Services Cancer Immunotherapy Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Immunotherapy Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Cancer Immunotherapy Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Cancer Immunotherapy Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Peregrine Pharmaceuticals Basic Information List
Table Viralytics Ltd Basic Information List
Table Immunomedics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure United States Cancer Immunotherapy Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Immunotherapy Production Forecast by Type (2016-2021)
Table United States Cancer Immunotherapy Consumption Forecast by Application (2016-2021)
Table United States Cancer Immunotherapy Sales Forecast by States (2016-2021)
Table United States Cancer Immunotherapy Sales Share Forecast by States (2016-2021)